Kevin Weil, formerly OpenAI's science lead, has launched Warp Sciences, an AI startup that trains robots to automate wet-lab tasks for drug discovery. The company has raised $215 million at an $865 million valuation, with Lightspeed leading the round alongside IVP, Premji Invest, and Lux Capital.
company
Warp Sciences
AI startup automating drug discovery labs